Altor Capital has high conviction on these 4 medtech plays for 2021

Brisbane-based Altor Capital portfolio manager David McNamee specialises in investing in emerging companies with a market capitalisation under $200 million. … Read More

The post Altor Capital has high conviction on these 4 medtech plays for 2021 appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *